{"id":36949,"date":"2017-02-16T11:52:28","date_gmt":"2017-02-16T11:52:28","guid":{"rendered":"http:\/\/humanitas.local\/diseases\/karcinom-hurtleo-vih-celija\/"},"modified":"2017-11-07T20:05:39","modified_gmt":"2017-11-07T20:05:39","slug":"karcinom-hurtleo-vih-celija","status":"publish","type":"disease","link":"https:\/\/www.humanitas.net\/sr\/diseases\/karcinom-hurtleo-vih-celija\/","title":{"rendered":"Karcinom Hurtleo-vih \u0107elija"},"content":{"rendered":"

Karcinom Hurtle-ovih \u0107elija, poznat kao karcinom oksifilnih \u0107elija, predstavlja redak tip karcinoma koji se javlja u \u0161titastoj \u017elezdi. <\/span><\/p>\n

\u0160titasta \u017elezda predstavlja organ oblika leptira sa bazom lokalizovanom u regiji vrata. Funkcija \u0161titaste \u017elezde jeste sekrecija hormona koji su od vitalnog zna\u010daja za metaboli\u010dke procese\u00a0 u organizmu.<\/span><\/p>\n

Karcinom Hurtle-ovih \u0107elija mo\u017ee biti znatno agresivnijeg toka u odnosu na ostale karcinome tiroidee. Naj\u010de\u0161\u0107i terapeutski pristup podrazumeva operativni pristup u cilju uklanjanja celokupne \u0161titaste \u017elezde.<\/span><\/p>\n

 <\/p>\n

Simptomi<\/span><\/h2>\n

Simptomi karcinoma Hurtle-ovih \u0107elija uklju\u010duju:<\/span><\/p>\n

Brzo-rastu\u0107i nodus vratne regije (ispod Adamove jabu\u010dice)<\/span><\/p>\n

Bol u predelu vrata ili grla<\/span><\/p>\n

Gubitak daha<\/span><\/p>\n

Promuklost ili druge glasovne promene<\/span><\/p>\n

Te\u0161ko\u0107e pri gutanju<\/span><\/p>\n

Navedeni simptomi nisu apsolutno indikativni za karcinom Hurtleo-vih \u0107elija. Mogu biti indikativni i za inflamatorna oboljenja \u0161titaste \u017elezde ili nekancerozna uve\u0107anja \u0161titaste \u017elezde (nodusi).<\/span><\/p>\n

\u00a0<\/span><\/p>\n

Uzroci<\/span><\/h2>\n

Ta\u010dan etiopatogenetski mehanizam nastanka karcinoma Hurtleovih \u0107elija jo\u0161 uvek je nepoznat.<\/span><\/p>\n

Karcinom nastaje prilikom gre\u0161aka u sopstvenoj DNA \u010delija. Naru\u0161ena struktura DNA mo\u017ee izazvati abnormalno funkcionalne gene \u0161to rezultuje u hiperprodukciji\u00a0 i poja\u010danom\u00a0 rastu abnormalnih \u0107elija sa formiranjem tumorske mase odnosno nakupina karcinomskih \u0107elija.<\/span><\/p>\n

 <\/p>\n

Fakori rizika<\/span><\/h2>\n

Faktori rizika za nastanak karcinoma Hurtle-ovih \u0107elija mogu biti:<\/span><\/p>\n

\u017denski pol<\/span><\/p>\n

Starije \u017eivotno doba<\/span><\/p>\n

Prethodna istorija terapeutskog zra\u010denja regije glave i vrata.<\/span><\/p>\n

 <\/p>\n

Komplikacije<\/span><\/h2>\n

Potencijalne komplikacije karcinoma Hurtle-ovih \u0107elija mogu uklju\u010divati: <\/span><\/p>\n

Pote\u0161ko\u0107e prilikom gutanja i disanja usled kompresije ezofagusa i du\u0161nika (traheje)<\/span><\/p>\n

\u0160irenje tumora u druge organe ili tkiva (metastaze).<\/span><\/p>\n","protected":false},"author":9,"featured_media":0,"template":"","yoast_head":"\nKarcinom Hurtleo-vih \u0107elija - Humanitas.net<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.humanitas.net\/sr\/diseases\/karcinom-hurtleo-vih-celija\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Karcinom Hurtleo-vih \u0107elija - Humanitas.net\" \/>\n<meta property=\"og:description\" content=\"Karcinom Hurtle-ovih \u0107elija, poznat kao karcinom oksifilnih \u0107elija, predstavlja redak tip karcinoma koji se javlja u \u0161titastoj \u017elezdi. \u0160titasta \u017elezda predstavlja organ oblika leptira sa bazom lokalizovanom u regiji vrata. Funkcija \u0161titaste \u017elezde jeste sekrecija hormona koji su od vitalnog zna\u010daja za metaboli\u010dke procese\u00a0 u organizmu. Karcinom Hurtle-ovih \u0107elija mo\u017ee biti znatno agresivnijeg toka u […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.humanitas.net\/sr\/diseases\/karcinom-hurtleo-vih-celija\/\" \/>\n<meta property=\"og:site_name\" content=\"Humanitas.net\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/HumanitasInternational\/\" \/>\n<meta property=\"article:modified_time\" content=\"2017-11-07T20:05:39+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary\" \/>\n<meta name=\"twitter:site\" content=\"@humanitasmilano\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.humanitas.net\/sr\/diseases\/karcinom-hurtleo-vih-celija\/\",\"url\":\"https:\/\/www.humanitas.net\/sr\/diseases\/karcinom-hurtleo-vih-celija\/\",\"name\":\"Karcinom Hurtleo-vih \u0107elija - Humanitas.net\",\"isPartOf\":{\"@id\":\"https:\/\/www.humanitas.net\/sr\/#website\"},\"datePublished\":\"2017-02-16T11:52:28+00:00\",\"dateModified\":\"2017-11-07T20:05:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.humanitas.net\/sr\/diseases\/karcinom-hurtleo-vih-celija\/#breadcrumb\"},\"inLanguage\":\"sr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.humanitas.net\/sr\/diseases\/karcinom-hurtleo-vih-celija\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.humanitas.net\/sr\/diseases\/karcinom-hurtleo-vih-celija\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.humanitas.net\/sr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bolesti\",\"item\":\"https:\/\/www.humanitas.net\/sr\/diseases\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Karcinom Hurtleo-vih \u0107elija\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.humanitas.net\/sr\/#website\",\"url\":\"https:\/\/www.humanitas.net\/sr\/\",\"name\":\"Humanitas.net\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.humanitas.net\/sr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.humanitas.net\/sr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"sr\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.humanitas.net\/sr\/#organization\",\"name\":\"Humanitas\",\"url\":\"https:\/\/www.humanitas.net\/sr\/\",\"sameAs\":[\"https:\/\/www.facebook.com\/HumanitasInternational\/\",\"https:\/\/twitter.com\/humanitasmilano\"],\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sr\",\"@id\":\"https:\/\/www.humanitas.net\/sr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.humanitas.net\/content\/uploads\/2017\/05\/logo-news-.png\",\"contentUrl\":\"https:\/\/www.humanitas.net\/content\/uploads\/2017\/05\/logo-news-.png\",\"width\":314,\"height\":61,\"caption\":\"Humanitas\"},\"image\":{\"@id\":\"https:\/\/www.humanitas.net\/sr\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Karcinom Hurtleo-vih \u0107elija - Humanitas.net","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.humanitas.net\/sr\/diseases\/karcinom-hurtleo-vih-celija\/","og_locale":"en_US","og_type":"article","og_title":"Karcinom Hurtleo-vih \u0107elija - Humanitas.net","og_description":"Karcinom Hurtle-ovih \u0107elija, poznat kao karcinom oksifilnih \u0107elija, predstavlja redak tip karcinoma koji se javlja u \u0161titastoj \u017elezdi. \u0160titasta \u017elezda predstavlja organ oblika leptira sa bazom lokalizovanom u regiji vrata. Funkcija \u0161titaste \u017elezde jeste sekrecija hormona koji su od vitalnog zna\u010daja za metaboli\u010dke procese\u00a0 u organizmu. Karcinom Hurtle-ovih \u0107elija mo\u017ee biti znatno agresivnijeg toka u […]","og_url":"https:\/\/www.humanitas.net\/sr\/diseases\/karcinom-hurtleo-vih-celija\/","og_site_name":"Humanitas.net","article_publisher":"https:\/\/www.facebook.com\/HumanitasInternational\/","article_modified_time":"2017-11-07T20:05:39+00:00","twitter_card":"summary","twitter_site":"@humanitasmilano","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.humanitas.net\/sr\/diseases\/karcinom-hurtleo-vih-celija\/","url":"https:\/\/www.humanitas.net\/sr\/diseases\/karcinom-hurtleo-vih-celija\/","name":"Karcinom Hurtleo-vih \u0107elija - Humanitas.net","isPartOf":{"@id":"https:\/\/www.humanitas.net\/sr\/#website"},"datePublished":"2017-02-16T11:52:28+00:00","dateModified":"2017-11-07T20:05:39+00:00","breadcrumb":{"@id":"https:\/\/www.humanitas.net\/sr\/diseases\/karcinom-hurtleo-vih-celija\/#breadcrumb"},"inLanguage":"sr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.humanitas.net\/sr\/diseases\/karcinom-hurtleo-vih-celija\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.humanitas.net\/sr\/diseases\/karcinom-hurtleo-vih-celija\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.humanitas.net\/sr\/"},{"@type":"ListItem","position":2,"name":"Bolesti","item":"https:\/\/www.humanitas.net\/sr\/diseases\/"},{"@type":"ListItem","position":3,"name":"Karcinom Hurtleo-vih \u0107elija"}]},{"@type":"WebSite","@id":"https:\/\/www.humanitas.net\/sr\/#website","url":"https:\/\/www.humanitas.net\/sr\/","name":"Humanitas.net","description":"","publisher":{"@id":"https:\/\/www.humanitas.net\/sr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.humanitas.net\/sr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"sr"},{"@type":"Organization","@id":"https:\/\/www.humanitas.net\/sr\/#organization","name":"Humanitas","url":"https:\/\/www.humanitas.net\/sr\/","sameAs":["https:\/\/www.facebook.com\/HumanitasInternational\/","https:\/\/twitter.com\/humanitasmilano"],"logo":{"@type":"ImageObject","inLanguage":"sr","@id":"https:\/\/www.humanitas.net\/sr\/#\/schema\/logo\/image\/","url":"https:\/\/www.humanitas.net\/content\/uploads\/2017\/05\/logo-news-.png","contentUrl":"https:\/\/www.humanitas.net\/content\/uploads\/2017\/05\/logo-news-.png","width":314,"height":61,"caption":"Humanitas"},"image":{"@id":"https:\/\/www.humanitas.net\/sr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.humanitas.net\/sr\/wp-json\/wp\/v2\/disease\/36949"}],"collection":[{"href":"https:\/\/www.humanitas.net\/sr\/wp-json\/wp\/v2\/disease"}],"about":[{"href":"https:\/\/www.humanitas.net\/sr\/wp-json\/wp\/v2\/types\/disease"}],"author":[{"embeddable":true,"href":"https:\/\/www.humanitas.net\/sr\/wp-json\/wp\/v2\/users\/9"}],"version-history":[{"count":0,"href":"https:\/\/www.humanitas.net\/sr\/wp-json\/wp\/v2\/disease\/36949\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.humanitas.net\/sr\/wp-json\/wp\/v2\/media?parent=36949"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}